R, G., H, A., DS, T., C, B., N, S. H., A, A., & T, A. (2025). Anthracycline and arsenic trioxide-based regimens for the treatment of acute promyelocytic leukemia: Thiamine levels monitoring importance. Current research in translational medicine, 73(3), 103520. https://doi.org/10.1016/j.retram.2025.103520
Chicago Style (17th ed.) CitationR, Garidi, Aftisse H, Tayeb DS, Benchouk C, Sari Hassoun N, Alem A, and Alsuliman T. "Anthracycline and Arsenic Trioxide-based Regimens for the Treatment of Acute Promyelocytic Leukemia: Thiamine Levels Monitoring Importance." Current Research in Translational Medicine 73, no. 3 (2025): 103520. https://doi.org/10.1016/j.retram.2025.103520.
MLA (9th ed.) CitationR, Garidi, et al. "Anthracycline and Arsenic Trioxide-based Regimens for the Treatment of Acute Promyelocytic Leukemia: Thiamine Levels Monitoring Importance." Current Research in Translational Medicine, vol. 73, no. 3, 2025, p. 103520, https://doi.org/10.1016/j.retram.2025.103520.